CARMEL, Ind., March 13, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and ...
In an interview on a local talk show, Alishba Yousuf addressed her acting break and whether or not actor-sister Syra Yousuf forces her to make a comeback. Laughing, Alishba said, "We don't force ...
CARMEL, Ind., Feb. 25, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and ...
Reports Q4 revenue $2M vs. $1.8M last year. Dr. Deepika Vuppalanchi, Chair and CEO of Syra Health (SYRA), said, “Since our IPO and listing on the Nasdaq nearly eighteen months ago, we have ...
Try Now>> See today’s best-performing stocks on TipRanks >> Read More on SYRA: Questions or Comments about the article? Write to [email protected] Syra Health NewsMORE Related Stocks Indices ...
2024 revenue of $8.0 million, up 45% compared to $5.5 million in 2023. For the full year of 2025, the Company expects low double-digit percentage revenue growth, with the main catalyst being the ...
Good morning, everyone, and thank you for joining us for Syra Health’s Fourth Quarter and Full Year 2024 Financial Results Conference Call. My name is Brett Maas of Hayden IR, and I direct ...
CARMEL, Ind., March 4, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through ...
Q4 2024 SG&A Expenses: 37% decline year-over-year. R&D Expenses for 2024: $585,000, up from $240,000 in 2023. Syra Health Corp (NASDAQ:SYRA) reported a 45% year-over-year revenue growth in 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results